Factor VIII inhibitor assay: quantitative and qualitative assay limitations and development needs.
White
G C
GC
Department of Medicine, Comprehensive Hemophilia Center, Chapel Hill, NC.
D000818:Animals; D000911:Antibodies, Monoclonal; D003429:Cross Reactions; D005169:Factor VIII / Q000037:antagonists & inhibitors* / Q000302:isolation & purification; D009316:National Institutes of Health (U.S.); D011994:Recombinant Proteins / Q000037:antagonists & inhibitors / Q000302:isolation & purification; D015203:Reproducibility of Results; D013552:Swine; D014481:United States
D000911:Antibodies, Monoclonal; D011994:Recombinant Proteins; D005169:Factor VIII